Impact de la COVID-19 sur les initiations et les renouvellements des biothérapies et traitements synthétiques ciblés en France

por Richette, P., Allez, M., Descamps, V., Geoffroy, M., Perray, L., Pilet, S., Maravic, M.
Publicado 2020

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery

por Mondot, S, Lepage, P, Seksik, P, Allez, M, Tréton, X, Bouhnik, Y, Colombel, J F, Leclerc, M, Pochart, P, Doré, J, Marteau, P
Publicado 2016

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

por Snowden, J A, Saccardi, R, Allez, M, Ardizzone, S, Arnold, R, Cervera, R, Denton, C, Hawkey, C, Labopin, M, Mancardi, G, Martin, R, Moore, J J, Passweg, J, Peters, C, Rabusin, M, Rovira, M, van Laar, J M, Farge, D
Publicado 2012

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative...

por Rup, B, Pallardy, M, Sikkema, D, Albert, T, Allez, M, Broet, P, Carini, C, Creeke, P, Davidson, J, De Vries, N, Finco, D, Fogdell-Hahn, A, Havrdova, E, Hincelin-Mery, A, C Holland, M, H Jensen, P E, Jury, E C, Kirby, H, Kramer, D, Lacroix-Desmazes, S, Legrand, J, Maggi, E, Maillère, B, Mariette, X, Mauri, C, Mikol, V, Mulleman, D, Oldenburg, J, Paintaud, G, R Pedersen, C, Ruperto, N, Seitz, R, Spindeldreher, S, Deisenhammer, F
Publicado 2015